CLINICAL TRIALS PROFILE FOR UNIPEN
✉ Email this page to a colleague
All Clinical Trials for UNIPEN
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00428844 ↗ | Study of Daptomycin in Subjects Undergoing Surgery for Osteomyelitis Associated With an Infected Prosthetic Caused by Staphylococci | Completed | Cubist Pharmaceuticals LLC | Phase 2 | 2007-06-26 | This is a research study designed to look at the efficacy and safety of daptomycin given at a dose of 6 mg/kg or 8 mg/kg in subjects being treated for prosthetic hip or knee infections caused by Staphylococci. These types of bacteria are among the most common types of bacteria causing infections of prosthetic joints. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for UNIPEN
Condition Name
Clinical Trial Locations for UNIPEN
Trials by Country
Clinical Trial Progress for UNIPEN
Clinical Trial Phase
Clinical Trial Sponsors for UNIPEN
Sponsor Name